Thresholds of oxidative stress in newly diagnosed diabetic patients on intensive glucose-control therapy.

Cellular and animal studies suggest that oxidative stress could be the central defect underlying both beta-cell dysfunction and insulin resistance in type 2 diabetes mellitus. A reduction of glycemic stress in diabetic patients on therapy alleviates systemic oxidative stress and improves insulin res...

Full description

Bibliographic Details
Main Authors: Rashmi Kulkarni, Jhankar Acharya, Saroj Ghaskadbi, Pranay Goel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4074157?pdf=render
id doaj-4f66ca6499704f74be0e2fd836d38ba6
record_format Article
spelling doaj-4f66ca6499704f74be0e2fd836d38ba62020-11-24T21:42:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e10089710.1371/journal.pone.0100897Thresholds of oxidative stress in newly diagnosed diabetic patients on intensive glucose-control therapy.Rashmi KulkarniJhankar AcharyaSaroj GhaskadbiPranay GoelCellular and animal studies suggest that oxidative stress could be the central defect underlying both beta-cell dysfunction and insulin resistance in type 2 diabetes mellitus. A reduction of glycemic stress in diabetic patients on therapy alleviates systemic oxidative stress and improves insulin resistance and beta-cell secretion. Monitoring oxidative stress systematically with glucose can potentially identify an individual's recovery trajectory. To determine a quantitative model of serial changes in oxidative stress, as measured via the antioxidant glutathione, we followed patients newly diagnosed with diabetes over 8 weeks of starting anti-diabetic treatment. We developed a mathematical model which shows recovery is marked with a quantal response. For each individual the model predicts three theoretical quantities: an estimate of maximal glutathione at low stress, a glucose threshold for half-maximal glutathione, and a rate at which recovery progresses. Individual patients are seen to vary considerably in their response to glucose control. Thus, model estimates can potentially be used to determine whether an individual patient's response is better or worse than average in terms of each of these indices; they can therefore be useful in reassessing treatment strategy. We hypothesize that this method can aid the personalization of effective targets of glucose control in anti-diabetic therapy.http://europepmc.org/articles/PMC4074157?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Rashmi Kulkarni
Jhankar Acharya
Saroj Ghaskadbi
Pranay Goel
spellingShingle Rashmi Kulkarni
Jhankar Acharya
Saroj Ghaskadbi
Pranay Goel
Thresholds of oxidative stress in newly diagnosed diabetic patients on intensive glucose-control therapy.
PLoS ONE
author_facet Rashmi Kulkarni
Jhankar Acharya
Saroj Ghaskadbi
Pranay Goel
author_sort Rashmi Kulkarni
title Thresholds of oxidative stress in newly diagnosed diabetic patients on intensive glucose-control therapy.
title_short Thresholds of oxidative stress in newly diagnosed diabetic patients on intensive glucose-control therapy.
title_full Thresholds of oxidative stress in newly diagnosed diabetic patients on intensive glucose-control therapy.
title_fullStr Thresholds of oxidative stress in newly diagnosed diabetic patients on intensive glucose-control therapy.
title_full_unstemmed Thresholds of oxidative stress in newly diagnosed diabetic patients on intensive glucose-control therapy.
title_sort thresholds of oxidative stress in newly diagnosed diabetic patients on intensive glucose-control therapy.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Cellular and animal studies suggest that oxidative stress could be the central defect underlying both beta-cell dysfunction and insulin resistance in type 2 diabetes mellitus. A reduction of glycemic stress in diabetic patients on therapy alleviates systemic oxidative stress and improves insulin resistance and beta-cell secretion. Monitoring oxidative stress systematically with glucose can potentially identify an individual's recovery trajectory. To determine a quantitative model of serial changes in oxidative stress, as measured via the antioxidant glutathione, we followed patients newly diagnosed with diabetes over 8 weeks of starting anti-diabetic treatment. We developed a mathematical model which shows recovery is marked with a quantal response. For each individual the model predicts three theoretical quantities: an estimate of maximal glutathione at low stress, a glucose threshold for half-maximal glutathione, and a rate at which recovery progresses. Individual patients are seen to vary considerably in their response to glucose control. Thus, model estimates can potentially be used to determine whether an individual patient's response is better or worse than average in terms of each of these indices; they can therefore be useful in reassessing treatment strategy. We hypothesize that this method can aid the personalization of effective targets of glucose control in anti-diabetic therapy.
url http://europepmc.org/articles/PMC4074157?pdf=render
work_keys_str_mv AT rashmikulkarni thresholdsofoxidativestressinnewlydiagnoseddiabeticpatientsonintensiveglucosecontroltherapy
AT jhankaracharya thresholdsofoxidativestressinnewlydiagnoseddiabeticpatientsonintensiveglucosecontroltherapy
AT sarojghaskadbi thresholdsofoxidativestressinnewlydiagnoseddiabeticpatientsonintensiveglucosecontroltherapy
AT pranaygoel thresholdsofoxidativestressinnewlydiagnoseddiabeticpatientsonintensiveglucosecontroltherapy
_version_ 1725916665938444288